Literature DB >> 9761669

Implications for function and therapy of a 2.9 A structure of binary-complexed antithrombin.

R Skinner1, W S Chang, L Jin, X Pei, J A Huntington, J P Abrahams, R W Carrell, D A Lomas.   

Abstract

The crystal structure of a binary complex of human antithrombin with a peptide of the same sequence as its reactive loop (P14-P3) has been determined at 2.9 A. The peptide binds as the middle strand s4A in the A beta-sheet, homologously to that of the reactive loop in the latent and cleaved forms of antithrombin. Peptide binding results in the complete expulsion of the hinge region of the loop from the A beta-sheet although the conformation differs from that of heparin-activated antithrombin. The 36-fold increase in the rate of reaction of the binary complex with factor Xa indicates that full loop expulsion alone is not sufficient for complete heparin activation of antithrombin but that this is also dependent on the overall conformation of the molecule. Previous studies have demonstrated that reactive loop peptides can block or reverse the polymerisation of serpins associated with cirrhosis and thrombosis. The antithrombin binary complex structure defines the precise localisation of the blocking peptide in a serpin and provides the basis for rational drug design for mimetics that will prevent polymerisation in vivo and so ameliorate the associated disease. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9761669     DOI: 10.1006/jmbi.1998.2083

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  20 in total

1.  Hydration effects of heparin on antithrombin probed by osmotic stress.

Authors:  Maria P McGee; Jie Liang; James Luba
Journal:  Biophys J       Date:  2002-02       Impact factor: 4.033

2.  Characterization of the conformational alterations, reduced anticoagulant activity, and enhanced antiangiogenic activity of prelatent antithrombin.

Authors:  Benjamin Richard; Richard Swanson; Sophia Schedin-Weiss; Ben Ramirez; Gonzalo Izaguirre; Peter G W Gettins; Steven T Olson
Journal:  J Biol Chem       Date:  2008-03-28       Impact factor: 5.157

3.  Small Molecule Probes That Perturb A Protein-protein Interface In Antithrombin.

Authors:  Dongyue Xin; Andreas Holzenburg; Kevin Burgess
Journal:  Chem Sci       Date:  2014-12-01       Impact factor: 9.825

4.  A redox-sensitive loop regulates plasminogen activator inhibitor type 2 (PAI-2) polymerization.

Authors:  Malgorzata Wilczynska; Sergei Lobov; Per-Ingvar Ohlsson; Tor Ny
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

5.  The heparin-binding site of antithrombin is crucial for antiangiogenic activity.

Authors:  Weiqing Zhang; Richard Swanson; Gonzalo Izaguirre; Yan Xiong; Lester F Lau; Steven T Olson
Journal:  Blood       Date:  2005-05-19       Impact factor: 22.113

6.  Mechanistic characterization and crystal structure of a small molecule inactivator bound to plasminogen activator inhibitor-1.

Authors:  Shih-Hon Li; Ashley A Reinke; Karen L Sanders; Cory D Emal; James C Whisstock; Jeanne A Stuckey; Daniel A Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

Review 7.  Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology.

Authors:  D A Lomas; H Parfrey
Journal:  Thorax       Date:  2004-06       Impact factor: 9.139

8.  Probing the local conformational change of alpha1-antitrypsin.

Authors:  Je-Hyun Baek; Hana Im; Un-Beom Kang; Ki Moon Seong; Cheolju Lee; Joon Kim; Myeong-Hee Yu
Journal:  Protein Sci       Date:  2007-07-27       Impact factor: 6.725

9.  Structural differences between active forms of plasminogen activator inhibitor type 1 revealed by conformationally sensitive ligands.

Authors:  Shih-Hon Li; Natalia V Gorlatova; Daniel A Lawrence; Bradford S Schwartz
Journal:  J Biol Chem       Date:  2008-04-24       Impact factor: 5.157

10.  Antiangiogenic forms of antithrombin specifically bind to the anticoagulant heparin sequence.

Authors:  Sophia Schedin-Weiss; Benjamin Richard; Rebecka Hjelm; Steven T Olson
Journal:  Biochemistry       Date:  2008-12-23       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.